3 results match your criteria: "Ascension St. Vincent's Heart Center of Indiana[Affiliation]"
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention.
Circulation
October 2024
Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland; Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Background: Accurate bleeding risk stratification after percutaneous coronary intervention (PCI) is important for treatment individualization. However, there is still an unmet need for a more precise and standardized identification of high bleeding risk patients. We derived and validated a novel bleeding risk score by augmenting the PRECISE-DAPT score with the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria.
View Article and Find Full Text PDFEndocarditis following transcatheter or surgical aortic valve replacement: What's the difference?
Catheter Cardiovasc Interv
April 2022
Department of Cardiology, Ascension St. Vincent's Heart Center of Indiana, Indianapolis, Indiana, USA.
The need for future coronary access following surgical or transcatheter aortic valve replacement.
Catheter Cardiovasc Interv
November 2021
Department of Surgery, East Carolina University, Greenville, North Carolina, USA.
The aim of the study was to estimate the percentage of Medicare patients needing coronary access for percutaneous coronary intervention (PCI) or coronary angiography following aortic valve replacement (AVR). Indications for TAVR have expanded to include younger and low-risk patients, raising the question of coronary access for future procedures. Medicare patients <80 years old with an AVR between 2011 and 2018 were included.
View Article and Find Full Text PDF